BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 28781150)

  • 1. 2016 guidelines for the use of antifungal agents in patients with invasive fungal diseases in Taiwan.
    Kung HC; Huang PY; Chen WT; Ko BS; Chen YC; Chang SC; Chuang YC; ; ; ;
    J Microbiol Immunol Infect; 2018 Feb; 51(1):1-17. PubMed ID: 28781150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2016 guideline strategies for the use of antifungal agents in patients with hematological malignancies or hematopoietic stem cell transplantation recipients in Taiwan.
    Ko BS; Chen WT; Kung HC; Wu UI; Tang JL; Yao M; Chen YC; Tien HF; Chang SC; Chuang YC; Lin DT; ; ; ; ; ;
    J Microbiol Immunol Infect; 2018 Jun; 51(3):287-301. PubMed ID: 28781151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combinatorial strategies for combating invasive fungal infections.
    Spitzer M; Robbins N; Wright GD
    Virulence; 2017 Feb; 8(2):169-185. PubMed ID: 27268286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The current treatment landscape: other fungal diseases (cryptococcosis, fusariosis and mucormycosis).
    Lortholary O; Fernández-Ruiz M; Perfect JR
    J Antimicrob Chemother; 2016 Nov; 71(suppl 2):ii31-ii36. PubMed ID: 27880667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003.
    Hsueh PR; Lau YJ; Chuang YC; Wan JH; Huang WK; Shyr JM; Yan JJ; Yu KW; Wu JJ; Ko WC; Yang YC; Liu YC; Teng LJ; Liu CY; Luh KT
    Antimicrob Agents Chemother; 2005 Feb; 49(2):512-7. PubMed ID: 15673726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining standards of CARE for invasive fungal diseases in solid organ transplant patients.
    Garcia-Vidal C; Carratalà J; Lortholary O
    J Antimicrob Chemother; 2019 Mar; 74(Suppl 2):ii16-ii20. PubMed ID: 31222312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination antifungal therapy for invasive fungal infections in children and adults.
    Hatipoglu N; Hatipoglu H
    Expert Rev Anti Infect Ther; 2013 May; 11(5):523-35. PubMed ID: 23627858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of mycoses in surgical patients -- review of the literature.
    Holzheimer RG; Dralle H
    Eur J Med Res; 2002 May; 7(5):200-26. PubMed ID: 12069912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antifungal therapy in invasive fungal infections.
    Chen SC; Playford EG; Sorrell TC
    Curr Opin Pharmacol; 2010 Oct; 10(5):522-30. PubMed ID: 20598943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caspofungin acetate for treatment of invasive fungal infections.
    Pacetti SA; Gelone SP
    Ann Pharmacother; 2003 Jan; 37(1):90-8. PubMed ID: 12503942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invasive Fungal Infections in the Pediatric Intensive Care Unit.
    Mantadakis E; Tragiannidis A
    Pediatr Infect Dis J; 2019 Sep; 38(9):e216-e218. PubMed ID: 31261360
    [No Abstract]   [Full Text] [Related]  

  • 12. Changes in the epidemiological landscape of invasive mould infections and disease.
    Lass-Flörl C; Cuenca-Estrella M
    J Antimicrob Chemother; 2017 Mar; 72(suppl_1):i5-i11. PubMed ID: 28355462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients.
    Neofytos D; Fishman JA; Horn D; Anaissie E; Chang CH; Olyaei A; Pfaller M; Steinbach WJ; Webster KM; Marr KA
    Transpl Infect Dis; 2010 Jun; 12(3):220-9. PubMed ID: 20113459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Invasive fungal infections: aspergillosis, candidiasis, mucormycosis].
    Cornely OA
    Drug Res (Stuttg); 2014 Nov; 64 Suppl 1():S14-5. PubMed ID: 25423419
    [No Abstract]   [Full Text] [Related]  

  • 15. How We Approach Combination Antifungal Therapy for Invasive Aspergillosis and Mucormycosis in Transplant Recipients.
    Haidar G; Singh N
    Transplantation; 2018 Nov; 102(11):1815-1823. PubMed ID: 29975240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management and diagnostic guidelines for fungal diseases in infectious diseases and clinical microbiology: critical appraisal.
    Leroux S; Ullmann AJ
    Clin Microbiol Infect; 2013 Dec; 19(12):1115-21. PubMed ID: 24118188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fungal Infections of the Central Nervous System in Children.
    McCarthy MW; Kalasauskas D; Petraitis V; Petraitiene R; Walsh TJ
    J Pediatric Infect Dis Soc; 2017 Sep; 6(3):e123-e133. PubMed ID: 28903523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Striking Back against Fungal Infections: The Utilization of Nanosystems for Antifungal Strategies.
    Du W; Gao Y; Liu L; Sai S; Ding C
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antifungal combination therapy in invasive fungal infections].
    Gellen-Dautremer J; Lanternier F; Dannaoui E; Lortholary O
    Rev Med Interne; 2010 Jan; 31(1):72-81. PubMed ID: 19767130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy of systemic mycoses in immunodeficiency].
    Just-Nübling G; Stille W
    Immun Infekt; 1991 Aug; 19(4):116-20. PubMed ID: 1937558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.